Han Chang Kang - Search Results

Year	Number of Results
2005	2
2006	1
2009	3
2010	2
2011	4
2012	6
2013	4
2014	8
2015	3
2016	2
2017	3
2018	11
2019	10
2020	9
2021	3

1

Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.

Yang G, Seok JK, Kang HC, Cho YY, Lee HS, Lee JY. Yang G, et al. Among authors: kang hc. Int J Mol Sci. 2020 Apr 20;21(8):2867. doi: 10.3390/ijms21082867. Int J Mol Sci. 2020. PMID: 32326002 Free PMC article. Review.

2

Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.

Battogtokh G, Choi YS, Kang DS, Park SJ, Shim MS, Huh KM, Cho YY, Lee JY, Lee HS, Kang HC. Battogtokh G, et al. Among authors: kang hc. Acta Pharm Sin B. 2018 Oct;8(6):862-880. doi: 10.1016/j.apsb.2018.05.006. Epub 2018 May 18. Acta Pharm Sin B. 2018. PMID: 30505656 Free PMC article. Review.

3

Mitochondria-targeting theranostics.

Kang HC. Kang HC. Biomater Res. 2018 Nov 8;22:34. doi: 10.1186/s40824-018-0145-7. eCollection 2018. Biomater Res. 2018. PMID: 30455977 Free PMC article. Review.

4

FBXW7-mediated stability regulation of signal transducer and activator of transcription 2 in melanoma formation.

Lee CJ, An HJ, Kim SM, Yoo SM, Park J, Lee GE, Kim WY, Kim DJ, Kang HC, Lee JY, Lee HS, Cho SJ, Cho YY. Lee CJ, et al. Among authors: kang hc. Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):584-594. doi: 10.1073/pnas.1909879116. Epub 2019 Dec 16. Proc Natl Acad Sci U S A. 2020. PMID: 31843895 Free PMC article.

5

Mitochondria-targeted drug delivery in cancers.

Cho H, Cho YY, Shim MS, Lee JY, Lee HS, Kang HC. Cho H, et al. Among authors: kang hc. Biochim Biophys Acta Mol Basis Dis. 2020 Aug 1;1866(8):165808. doi: 10.1016/j.bbadis.2020.165808. Epub 2020 Apr 22. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32333953 Review.

6

Stat2 stability regulation: an intersection between immunity and carcinogenesis.

Lee CJ, An HJ, Cho ES, Kang HC, Lee JY, Lee HS, Cho YY. Lee CJ, et al. Among authors: kang hc. Exp Mol Med. 2020 Sep;52(9):1526-1536. doi: 10.1038/s12276-020-00506-6. Epub 2020 Sep 25. Exp Mol Med. 2020. PMID: 32973222 Free article. Review.

7

Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.

Sivakumar P, Kim S, Kang HC, Shim MS. Sivakumar P, et al. Among authors: kang hc. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 May;11(3):e1543. doi: 10.1002/wnan.1543. Epub 2018 Aug 2. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019. PMID: 30070426 Review.

8

Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment.

Battogtokh G, Cho YY, Lee JY, Lee HS, Kang HC. Battogtokh G, et al. Among authors: kang hc. Front Pharmacol. 2018 Aug 17;9:922. doi: 10.3389/fphar.2018.00922. eCollection 2018. Front Pharmacol. 2018. PMID: 30174604 Free PMC article. Review.

9

Polymeric gene carriers.

Kang HC, Lee M, Bae YH. Kang HC, et al. Crit Rev Eukaryot Gene Expr. 2005;15(4):317-42. doi: 10.1615/critreveukargeneexpr.v15.i4.30. Crit Rev Eukaryot Gene Expr. 2005. PMID: 16472063 Review.

10

Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome.

Yang G, Jang JH, Kim SW, Han SH, Ma KH, Jang JK, Kang HC, Cho YY, Lee HS, Lee JY. Yang G, et al. Among authors: kang hc. Int J Mol Sci. 2020 Apr 17;21(8):2790. doi: 10.3390/ijms21082790. Int J Mol Sci. 2020. PMID: 32316419 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results